Found this article earlier - IGF1 seems to be showing preliminary efficacy in another type of autism.
http://sfari.org/news-and-opinion/c...or-shows-promise-for-phelan-mcdermid-syndrome
Augurs well for nnz-2566.
If we can manage FDA approval for Rett, it really does open the doors across the autism spectrum - truly a class effect!
Found this article earlier - IGF1 seems to be showing...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.61 |
Change
0.400(2.63%) |
Mkt cap ! $1.994B | |||
| Open | High | Low | Value | Volume |
| $15.51 | $15.82 | $15.46 | $5.754M | 368.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 401 | $18.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.49 | 8860 | 2 |
View Market Depth
| Last trade - 15.59pm 30/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |